Medicines List

Select category
  • Desctription

    Pulmohyperta tablets contains bosentan and belong to a group of medicines called “endothelin receptor antagonist”.

    Bosentan is a dual endothelin receptor antagonist (ERA) with affinity for both endothelin A and B (ETA and ETB) receptors. Bosentan decreases both pulmonary and systemic vascular resistance resulting in increased cardiac output without increasing heart rate.

    Indications

    Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and symptoms in patients with WHO functional class III. Efficacy has been shown in:
    • Primary (idiopathic and heritable) pulmonary arterial hypertension
    • Pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease
    • Pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger’s physiology
    Some improvements have also been shown in patients with pulmonary arterial hypertension WHO functional class II.

    Subject to medical prescription

    Pharmaceutical form: Pulmohyperta 62,5 mg film-coated tablets x 56 tablets

    NHIF code:

    ICD: I27.0; M34.0, M34.1, M34.2, M34.8;  Q21.8

    Pharmaceutical form: Pulmohyperta 125 mg film-coated tablets x 56 tablets

    NHIF code: CG192

    ICD: I27.0; M34.0, M34.1, M34.2, M34.8;  Q21.8

    АТС: C02KX01

  • Description

    Diab MR is a medicine that reduces blood sugar levels (oral antidiabetic medicine belonging to the sulfonylurea group).

    Indications

    Diab MR is used in a certain form of diabetes (type 2 diabetes mellitus) in adults, when diet, exercise and weight loss alone do not have an adequate effect on keeping blood sugar at the correct level.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 30 mg modified-release tablets

  • Description

    Co-Paxene is a combination of perindopril and indapamide, used for treatment of high blood pressure (hypertension) in adults.

    Indications

    Co-Paxene 2 mg/0.625 mg tablets
    – treatment of essential hypertension in adults.

    Co-Paxene 4 mg/1.25 mg tablets
    – treatment of essential hypertension;
    – Co-Paxene 4 mg/1.25 mg tablets is indicated in patients whose blood pressure is not adequately controlled on perindopril alone.

    Subject to medical prescription.

    Concentrations and pharmaceutical form: 2 mg/0.625 mg; 4 mg/1.25 mg tablets

  • Description

    Sodium chloride is the main salt for maintaining plasma and isotonicity of other tissues, thus affecting the water and electrolyte balance. In patients who do not have dehydration, excess sodium chloride leads to a salt diuretic effect, while in the presence of dehydration, it acts as a source of water and electrolytes.

    Indications

    Sodium chloride-Tchaikapharma is used for the following indications:
    – Dissolution of powdered dosage forms for injection;
    – Dilution of concentrated solutions for injection;
    – Flushing and replenishment of intravenous catheters and cannulas for temporary access.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 0.9 % solution for injection